Topiramate

Generic Name
Topiramate
Brand Names
Eprontia, Qsymia, Qudexy, Topamax, Trokendi
Drug Type
Small Molecule
Chemical Formula
C12H21NO8S
CAS Number
97240-79-4
Unique Ingredient Identifier
0H73WJJ391
Background

Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines. It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults. Since 2012, the extended-release formulation has been approved in combination with phentermine for chronic weight management therapy in adults.
...

Indication

Topiramate is indicated for the following conditions: 1)Monotherapy for partial onset or primary generalized tonic-clonic seizures for patients 2 years of age and above 2)Adjunctive therapy for partial onset seizures or primary generalized tonic-clonic seizures for both adult and pediatric patients above 2 years old 3)Adjunctive therapy for seizures associat...

Associated Conditions
Alcohol Dependency, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Generalized Tonic-Clonic Seizures, Lennox-Gastaut Syndrome, Migraine, Moods Disorders, Partial-Onset Seizures, Seizures, Weight
Associated Therapies
Chronic Weight Management therapy, Weight Reduction
Clinical Trials
Related News

Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care

First Posted Date
2024-07-12
Last Posted Date
2024-07-12
Lead Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Target Recruit Count
460
Registration Number
NCT06499116

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Phase 1
Not yet recruiting
Conditions
HIV-1-infection
HIV I Infection
Hiv
HIV Infections
Interventions
Drug: Topiramate
First Posted Date
2024-02-28
Last Posted Date
2024-02-28
Lead Sponsor
Erasmus Medical Center
Target Recruit Count
12
Registration Number
NCT06282783
Locations
🇳🇱

Erasmus Medical Centre, Rotterdam, Netherlands

Zolmitriptane as Prophylaxis for Chilhood Migraine

Phase 4
Recruiting
Conditions
Migraine
Interventions
Drug: zolmitriptanee
Drug: topiramate
Drug: Valproate
First Posted Date
2023-10-18
Last Posted Date
2023-10-18
Lead Sponsor
Tanta University
Target Recruit Count
90
Registration Number
NCT06089356
Locations
🇪🇬

Kafrelsheikh University, Tanta, Kafrelsheikh, Egypt

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

Phase 4
Recruiting
Conditions
Obesity
Interventions
Drug: Placebo
Drug: Topiramate
Drug: Phentermine
First Posted Date
2023-08-04
Last Posted Date
2024-11-18
Lead Sponsor
University of California, Irvine
Target Recruit Count
120
Registration Number
NCT05975580
Locations
🇺🇸

University of California Irvine Medical Center, Orange, California, United States

Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study

First Posted Date
2023-07-24
Last Posted Date
2023-07-24
Lead Sponsor
Lady Hardinge Medical College
Target Recruit Count
70
Registration Number
NCT05958160
Locations
🇮🇳

Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi, Delhi, India

Anti-obesity Pharmacotherapy and Inflammation

First Posted Date
2023-03-06
Last Posted Date
2024-05-23
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
24
Registration Number
NCT05756764
Locations
🇺🇸

Ochsner Health System - Biospecimen, New Orleans, Louisiana, United States

🇺🇸

LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO, New Orleans, Louisiana, United States

Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

First Posted Date
2023-02-28
Last Posted Date
2024-11-22
Lead Sponsor
AbbVie
Target Recruit Count
545
Registration Number
NCT05748483
Locations
🇨🇿

Praglandia /ID# 247511, Prague, Praha 5, Czechia

🇩🇪

Universitaetsklinikum Carl Gustav Carus Dresden /ID# 246040, Dresden, Sachsen, Germany

🇧🇪

Universitair Ziekenhuis Brussel /ID# 246959, Jette, Bruxelles-Capitale, Belgium

and more 78 locations

Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics

First Posted Date
2022-12-23
Last Posted Date
2023-08-22
Lead Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Target Recruit Count
60
Registration Number
NCT05663749
Locations
🇮🇳

Dept of Psychiatry, Aiims, Bhubaneswar, Bhubaneswar, Odisha, India

The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss

First Posted Date
2022-06-03
Last Posted Date
2024-02-16
Lead Sponsor
Chang Gung Memorial Hospital
Target Recruit Count
140
Registration Number
NCT05403229
Locations
🇨🇳

New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan

Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas

First Posted Date
2021-02-18
Last Posted Date
2021-04-30
Lead Sponsor
Université de Sherbrooke
Target Recruit Count
56
Registration Number
NCT04759196
Locations
🇨🇦

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy